<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-WFC8LPEF</identifier><date>2019</date><creator>Sollner Dolenc, Marija</creator><creator>Stanojević, Mark</creator><relation>documents/doc/W/URN_NBN_SI_doc-WFC8LPEF_001.pdf</relation><relation>documents/doc/W/URN_NBN_SI_doc-WFC8LPEF_001.txt</relation><format format_type="issue">5</format><format format_type="volume">70</format><format format_type="type">article</format><format format_type="extent">str. 345-354</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">4857201</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-WFC8LPEF</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">bioakumulativnost</subject><subject language_type_id="slv">obstojnost</subject><subject language_type_id="slv">ocena tveganja za okolje (ERA)</subject><subject language_type_id="slv">Okolje</subject><subject language_type_id="slv">predvidena koncentracija v okolju (PEC)</subject><subject language_type_id="slv">strupenost</subject><subject language_type_id="slv">Zdravila</subject><title>Environmental risk assessment of medicinal products for human use</title><title>Ocenjevanje tveganja za okolje za humana zdravila</title></Record>